Tracker › Companies › Lisata Therapeutics, Inc.
4 No sign of it. We found no public evidence tying Lisata Therapeutics, Inc.'s cuts to AI.
Every tracked 2026 layoff at Lisata Therapeutics, Inc., newest first. Scores are 0–100: how strongly the public evidence ties the cuts to AI. Sources are linked on each one.
AI score 4/100 (Minimal) · 80% interval 4–5 · evidence grade D · US · Pharma / Chemicals
Stated reason: On August 3, 2026, the board of directors (the “Board”) of Lisata Therapeutics, Inc. (the “Company”) approved a reduction in workforce by approximately 72%, effective immediately. The decision was based on cost-reduction initiatives intended to reduce the Company’s ongoing operating expenses and maximize shareholder value as the Company plans to pursue strategic options. Affected employees will be offered separation …
Why 4: Merger / acquisition integration · Drivers: industry AI exposure +0.5, contrary evidence −0.2
Evidence: SEC filing. Signals: attribution 0.0, primary source 0.0, exec statement 0.0, role exposure 0.86, industry exposure 0.712, AI investment 0.0, contrary evidence 0.15 · named roles: Computer and Information Systems Managers, General and Operations Managers, Market Research Analysts and Marketing Specialists, Marketing Managers, News Analyst
Headcount basis: not disclosed
Scores are evidence-based estimates from a published model, not findings that AI caused any layoff. Spot something wrong or missing? Tell us.
Other Health Care & Pharma layoffs we track.
Health Care & Pharma · 738 workers
Health Care & Pharma · 322 workers
Health Care & Pharma · 250 workers
Health Care & Pharma · 108 workers
Health Care & Pharma · 85 workers
Health Care & Pharma
